1. Home
  2. VTAK vs UPC Comparison

VTAK vs UPC Comparison

Compare VTAK & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTAK
  • UPC
  • Stock Information
  • Founded
  • VTAK 2002
  • UPC 1998
  • Country
  • VTAK United States
  • UPC China
  • Employees
  • VTAK N/A
  • UPC 225
  • Industry
  • VTAK Medical/Dental Instruments
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTAK Health Care
  • UPC Health Care
  • Exchange
  • VTAK Nasdaq
  • UPC Nasdaq
  • Market Cap
  • VTAK 1.4M
  • UPC 1.2M
  • IPO Year
  • VTAK 2018
  • UPC 2021
  • Fundamental
  • Price
  • VTAK $0.46
  • UPC $0.51
  • Analyst Decision
  • VTAK
  • UPC
  • Analyst Count
  • VTAK 0
  • UPC 0
  • Target Price
  • VTAK N/A
  • UPC N/A
  • AVG Volume (30 Days)
  • VTAK 728.8K
  • UPC 803.8K
  • Earning Date
  • VTAK 11-13-2024
  • UPC 01-01-0001
  • Dividend Yield
  • VTAK N/A
  • UPC N/A
  • EPS Growth
  • VTAK N/A
  • UPC N/A
  • EPS
  • VTAK N/A
  • UPC N/A
  • Revenue
  • VTAK $399,000.00
  • UPC $26,725,919.00
  • Revenue This Year
  • VTAK $38.46
  • UPC N/A
  • Revenue Next Year
  • VTAK $533.33
  • UPC N/A
  • P/E Ratio
  • VTAK N/A
  • UPC N/A
  • Revenue Growth
  • VTAK 27.07
  • UPC N/A
  • 52 Week Low
  • VTAK $0.31
  • UPC $0.12
  • 52 Week High
  • VTAK $8.40
  • UPC $4.32
  • Technical
  • Relative Strength Index (RSI)
  • VTAK 50.82
  • UPC 33.53
  • Support Level
  • VTAK $0.40
  • UPC $0.48
  • Resistance Level
  • VTAK $0.51
  • UPC $0.54
  • Average True Range (ATR)
  • VTAK 0.07
  • UPC 0.04
  • MACD
  • VTAK -0.00
  • UPC 0.09
  • Stochastic Oscillator
  • VTAK 32.83
  • UPC 12.78

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: